Britannia Life Sciences Inc.
BLSIF
$0.0666
-$0.0114-14.62%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.47M | -1.51M | -1.51M | -1.02M | 394.00K |
| Total Depreciation and Amortization | 89.60K | 89.00K | 89.00K | 99.50K | 113.60K |
| Total Amortization of Deferred Charges | 60.30K | 60.30K | 60.30K | 26.40K | -- |
| Total Other Non-Cash Items | 869.80K | 1.12M | 1.12M | 281.40K | -815.10K |
| Change in Net Operating Assets | 182.80K | 812.30K | 812.30K | 1.11M | 1.17M |
| Cash from Operations | -270.60K | 570.10K | 806.80K | 735.60K | 1.10M |
| Capital Expenditure | -10.90K | -10.90K | -10.90K | -6.60K | 80.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -687.00K | -687.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -312.20K | -194.50K | -194.50K | -138.30K | -89.90K |
| Cash from Investing | -323.10K | -205.40K | -336.70K | -963.20K | -828.20K |
| Total Debt Issued | 771.50K | 771.50K | 771.50K | 771.50K | -- |
| Total Debt Repaid | -1.18M | -1.17M | -1.17M | -1.08M | -974.80K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -498.80K | -498.80K | -498.80K | -498.80K |
| Cash from Financing | -290.40K | -648.80K | -1.07M | -1.01M | -1.50M |
| Foreign Exchange rate Adjustments | 27.90K | 41.60K | 41.60K | 82.40K | -33.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -856.20K | -242.40K | -534.30K | -1.13M | -1.24M |